KEGG   PATHWAY: bta05416
Entry
bta05416                    Pathway                                
Name
Viral myocarditis - Bos taurus (cow)
Description
Myocarditis is a cardiac disease associated with inflammation and injury of the myocardium. It results from various etiologies, both noninfectious and infectious, but coxsackievirus B3 (CVB3) is still considered the dominant etiological agent. Myocarditis may be caused by direct cytopathic effects of virus, a pathologic immune response to persistent virus, or autoimmunity triggered by the viral infection. The virus enters the myocyte through internalization of the coxsackie-adenoviral receptor (CAR) and its coreceptor, decay-accelerating factor (DAF). Viral proteases cleave various proteins in the host cell. One example is viral protease 2A, which cleaves eukaryote initiation factor 4G (eIF4G) and the dystrophin protein, resulting in a complete shutdown of cap-dependent RNA translation and cytoskeletal destruction in infected cardiomyocytes, respectively. CVB3 also cleaves the member of the Bcl-2 family Bid, leading to apoptosis. CVB3 infection also induces the cleavage of cyclin D protein through a proteasome-dependent pathway, leading to the host cell-growth arrest. Viral infection and necrosis of myocytes may lead to the release of intracellular antigens, resulting in activation of self-reactive T cells. CVB infection is a significant cause of dilated cardiomyopathy (DCM) as well as myocarditis. Epidemiologically, myocarditis underlies a significant portion of patients with DCM.
Class
Human Diseases; Cardiovascular disease
Pathway map
bta05416  Viral myocarditis
bta05416

Organism
Bos taurus (cow) [GN:bta]
Gene
281733  CXADR; coxsackievirus and adenovirus receptor homolog precursor [KO:K06788]
518609  CD55; complement decay-accelerating factor [KO:K04006]
527263  FYN; tyrosine-protein kinase Fyn [KO:K05703] [EC:2.7.10.2]
281040  CAV1; caveolin-1 [KO:K06278]
540876  ABL1; tyrosine-protein kinase ABL1 [KO:K06619] [EC:2.7.10.2]
511845  ABL2; tyrosine-protein kinase ABL2 [KO:K08887] [EC:2.7.10.2]
281440  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
327671  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
619066  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
613989  SSPN; sarcospan [KO:K22194]
541308  SGCA; alpha-sarcoglycan precursor [KO:K12565]
535372  SGCB; beta-sarcoglycan [KO:K12566]
506155  SGCG; gamma-sarcoglycan [KO:K12564]
517059  SGCD; delta-sarcoglycan [KO:K12563]
407209  SGCE; epsilon-sarcoglycan [KO:K27061]
132344024  SGCZ; zeta-sarcoglycan [KO:K27062]
506387  LAMA1; laminin subunit alpha-1 isoform X1 [KO:K05637]
100138434  LAMA2; laminin subunit alpha-2 [KO:K05637]
281439  DAG1; dystroglycan 1 precursor [KO:K06265]
615310  CAV3; caveolin-3 [KO:K12959]
536132  NOS1; nitric oxide synthase 1 isoform X1 [KO:K13240] [EC:1.14.13.39]
527488  SNTA1; alpha-1-syntrophin [KO:K24063]
786534  SNTB2; beta-2-syntrophin [KO:K24064]
617927  SNTB1; beta-1-syntrophin [KO:K24064]
541153  DTNA; dystrobrevin alpha [KO:K26998]
537655  DMD; dystrophin isoform X11 [KO:K10366]
404122  ACTG1; actin, cytoplasmic 2 [KO:K05692]
280979  ACTB; actin, cytoplasmic 1 [KO:K05692]
286870  EIF4G2; eukaryotic translation initiation factor 4 gamma 2 [KO:K03260]
444858  EIF4G1; eukaryotic translation initiation factor 4 gamma 1 isoform X10 [KO:K03260]
534618  EIF4G3; eukaryotic translation initiation factor 4 gamma 3 isoform X2 [KO:K03260]
524530  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
507481  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
510373  BID; BH3-interacting domain death agonist [KO:K04726]
510767  CYCS; cytochrome c [KO:K08738]
781996  CYCT; cytochrome c 2 [KO:K08738]
100847700  cytochrome c [KO:K08738]
100847304  cytochrome c-like [KO:K08738]
112447733  cytochrome c-like [KO:K08738]
100140945  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
408016  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
282714  MYH7; myosin-7 [KO:K17751]
100296004  MYH6; myosin-6 [KO:K17751]
282387  CD40LG; CD40 ligand [KO:K03161]
112445051  CD40 ligand [KO:K03161]
286849  CD40; tumor necrosis factor receptor superfamily member 5 precursor [KO:K03160]
282490  BOLA-DMA; HLA class II histocompatibility antigen, DM alpha chain precursor [KO:K06752]
282491  BOLA-DMB; major histocompatibility complex, class II, DM beta precursor [KO:K06752]
282493  BOLA-DOB; HLA class II histocompatibility antigen, DO beta chain precursor [KO:K06752]
282494  BOLA-DQA5; major histocompatibility complex, class II, DQ alpha 5 precursor [KO:K06752]
282495  BOLA-DQB; major histocompatibility complex, class II, DQ beta precursor [KO:K06752]
282498  BOLA-DYB; major histocompatibility complex, class II, DY beta precursor [KO:K06752]
282535  BOLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]
282530  BOLA-DRB3; major histocompatibility complex, class II, DRB3 [KO:K06752]
525727  BOLA-DOA; HLA class II histocompatibility antigen, DO alpha chain precursor [KO:K06752]
506214  BOLA-DRA; major histocompatibility complex, class II, DR alpha precursor [KO:K06752]
539241  BLA-DQB; boLa class II histocompatibility antigen, DQB*0101 beta chain precursor [KO:K06752]
100848815  SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like precursor [KO:K06752]
282497  BOLA-DYA; major histocompatibility complex, class II, DY alpha precursor [KO:K06752]
618722  DSB; MHC class II antigen DS beta [KO:K06752]
538700  BOLA-DRB2; HLA class II histocompatibility antigen, DR beta 5 chain isoform X3 [KO:K06752]
100300850  T cell receptor alpha variable 18 [KO:K10784]
509513  uncharacterized LOC509513 precursor [KO:K10785]
100300510  T cell receptor beta constant 1 [KO:K10785]
407173  JSP.1; MHC Class I JSP.1 precursor [KO:K06751]
512672  major histocompatibility complex, class I precursor [KO:K06751]
515712  BOLA; MHC class I heavy chain isoform 1 precursor [KO:K06751]
767904  MGC126945; LOW QUALITY PROTEIN: uncharacterized protein LOC767904 [KO:K06751]
507917  BOLA class I histocompatibility antigen, alpha chain BL3-6 isoform X1 [KO:K06751]
510417  BOLA-NC1; non-classical MHC class I antigen precursor [KO:K06751]
533050  BoLA; major histocompatibility complex, class I, A precursor [KO:K06751]
616942  major histocompatibility complex, class I, A-like precursor [KO:K06751]
407131  CD80; T-lymphocyte activation antigen CD80 [KO:K05412]
414345  CD86; T-lymphocyte activation antigen CD86 [KO:K05413]
281050  CD28; T-cell-specific surface glycoprotein CD28 precursor [KO:K06470]
369025  PRF1; perforin-1 precursor [KO:K07818]
281874  ITGAL; integrin alpha-L precursor [KO:K05718]
281877  ITGB2; integrin beta-2 precursor [KO:K06464]
281839  ICAM1; intercellular adhesion molecule 1 precursor [KO:K06490]
524810  IgM precursor [KO:K06856]
100300716  immunoglobulin heavy variable 4-38-2 [KO:K06856]
100300806  immunoglobulin heavy variable 4-59 isoform X1 [KO:K06856]
104968484  immunoglobulin heavy variable 4-59 [KO:K06856]
Reference
  Authors
Esfandiarei M, McManus BM
  Title
Molecular biology and pathogenesis of viral myocarditis.
  Journal
Annu Rev Pathol 3:127-55 (2008)
DOI:10.1146/annurev.pathmechdis.3.121806.151534
Reference
  Authors
Badorff C, Knowlton KU
  Title
Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
  Journal
Med Microbiol Immunol 193:121-6 (2004)
DOI:10.1007/s00430-003-0189-7
Reference
  Authors
Maekawa Y, Ouzounian M, Opavsky MA, Liu PP
  Title
Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.
  Journal
Circulation 115:5-8 (2007)
DOI:10.1161/CIRCULATIONAHA.106.670554
Reference
  Authors
Pankuweit S, Portig I, Maisch B
  Title
Pathophysiology of cardiac inflammation: molecular mechanisms.
  Journal
Herz 27:669-76 (2002)
DOI:10.1007/s00059-002-2421-4
Reference
  Authors
Gao G, Luo H
  Title
The ubiquitin-proteasome pathway in viral infections.
  Journal
Can J Physiol Pharmacol 84:5-14 (2006)
DOI:10.1139/y05-144
Reference
  Authors
Coyne CB, Bergelson JM
  Title
Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.
  Journal
Cell 124:119-31 (2006)
DOI:10.1016/j.cell.2005.10.035
Reference
  Authors
Badorff C, Lee GH, Knowlton KU
  Title
Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.
  Journal
Herz 25:227-32 (2000)
DOI:10.1007/s000590050011
Reference
  Authors
Knowlton KU
  Title
CVB infection and mechanisms of viral cardiomyopathy.
  Journal
Curr Top Microbiol Immunol 323:315-35 (2008)
DOI:10.1007/978-3-540-75546-3_15
Reference
  Authors
Castellano G, Affuso F, Di Conza P, Fazio S
  Title
Myocarditis and dilated cardiomyopathy: possible connections and treatments.
  Journal
J Cardiovasc Med (Hagerstown) 9:666-71 (2008)
DOI:10.2459/JCM.0b013e3282f3e9c2
Reference
  Authors
Cooper LT Jr
  Title
Myocarditis.
  Journal
N Engl J Med 360:1526-38 (2009)
DOI:10.1056/NEJMra0800028
Reference
  Authors
Kawai C
  Title
From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
  Journal
Circulation 99:1091-100 (1999)
DOI:10.1161/01.CIR.99.8.1091
Reference
  Authors
Liu PP, Mason JW
  Title
Advances in the understanding of myocarditis.
  Journal
Circulation 104:1076-82 (2001)
DOI:10.1161/hc3401.095198
Reference
  Authors
Mason JW
  Title
Myocarditis and dilated cardiomyopathy: an inflammatory link.
  Journal
Cardiovasc Res 60:5-10 (2003)
DOI:10.1016/S0008-6363(03)00437-1
Reference
  Authors
Tam PE
  Title
Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.
  Journal
Viral Immunol 19:133-46 (2006)
DOI:10.1089/vim.2006.19.133
Related
pathway
bta03050  Proteasome
bta04110  Cell cycle
bta04210  Apoptosis
bta04260  Cardiac muscle contraction
bta04512  ECM-receptor interaction
bta04612  Antigen processing and presentation
bta04660  T cell receptor signaling pathway
bta05414  Dilated cardiomyopathy
KO pathway
ko05416   
LinkDB

DBGET integrated database retrieval system